What is the recommended treatment for herpes zoster?

Herpes Zoster Treatment

For acute herpes zoster, initiate antiviral therapy with valacyclovir, famciclovir, or acyclovir within 72 hours of rash onset to reduce disease severity, duration, and acute pain. 1, 2

Antiviral Therapy - First-Line Treatment

The cornerstone of herpes zoster management is prompt antiviral therapy. Three oral antivirals are equally effective and well-tolerated 2, 3:

• Valacyclovir (preferred for convenience)
• Famciclovir (preferred for convenience)
• Acyclovir (requires more frequent dosing)
• Brivudin (where available - once daily dosing) 3

Critical Timing

Start antivirals within 72 hours of rash appearance - this window is essential for maximum benefit 1, 4, 3. Earlier initiation (within 48 hours) is even better 3.

Mandatory Treatment Indications

Antiviral therapy is urgently indicated in 3:

• All patients ≥50 years of age
• Any age with head/neck involvement (especially zoster ophthalmicus)
• Immunocompromised patients at any age
• Severe trunk or extremity involvement
• Patients with severe atopic dermatitis or eczema

Relative Indications

Patients <50 years with uncomplicated trunk/extremity zoster have only relative indications for treatment 3.

Pain Management - Equally Critical

Achieving painlessness is the primary therapeutic goal 3. Pain management should be initiated simultaneously with antivirals:

Acute Pain Control

• Appropriately dosed analgesics combined with
• Neuroactive agents (e.g., amitriptyline) 3

Corticosteroids

May shorten acute pain duration but do not prevent postherpetic neuralgia (PHN) 3. Use is adjunctive, not primary.

Postherpetic Neuralgia Prevention and Treatment

PHN occurs in approximately 20% of patients and is defined as pain persisting ≥90 days after acute herpes zoster 1.

Preventive Strategy

For high-risk patients (age ≥50, severe acute pain), consider early initiation of gabapentin or amitriptyline at herpes zoster onset 4.

PHN Treatment Algorithm (in order of recommendation) 4:

First-line options:

• Topical lidocaine or capsaicin (for localized pain)
• Gabapentin or pregabalin (anticonvulsants)
• Tricyclic antidepressants (amitriptyline, nortriptyline, desipramine)

Second-line (for severe pain):

• Opioid analgesics (tramadol, morphine, oxycodone, methadone)

Monitoring for Complications

In immunocompromised patients receiving oral antivirals, actively monitor for cutaneous or visceral dissemination - if present, switch immediately to intravenous antiviral therapy 5.

Common Pitfalls to Avoid

1. Delaying treatment beyond 72 hours - efficacy drops significantly
2. Undertreating pain - inadequate analgesia increases PHN risk
3. Assuming antivirals prevent PHN - they reduce acute pain but have minimal effect on PHN development 5
4. Missing zoster ophthalmicus - requires urgent antiviral therapy regardless of age
5. Using oral antivirals alone in disseminated disease - requires IV therapy

Key Evidence Considerations

The evidence strongly supports antiviral use within 72 hours for reducing acute symptoms and healing time 1, 2, 5. However, antivirals do not significantly impact postherpetic neuralgia rates 5, making aggressive pain management from disease onset critical. The newer agents (valacyclovir, famciclovir) offer better bioavailability and simpler dosing than acyclovir but similar efficacy 5.